266 related articles for article (PubMed ID: 20080688)
1. Development of a mouse model for sporadic and metastatic colon tumors and its use in assessing drug treatment.
Hung KE; Maricevich MA; Richard LG; Chen WY; Richardson MP; Kunin A; Bronson RT; Mahmood U; Kucherlapati R
Proc Natl Acad Sci U S A; 2010 Jan; 107(4):1565-70. PubMed ID: 20080688
[TBL] [Abstract][Full Text] [Related]
2. Rapamycin inhibition of polyposis and progression to dysplasia in a mouse model.
Hardiman KM; Liu J; Feng Y; Greenson JK; Fearon ER
PLoS One; 2014; 9(4):e96023. PubMed ID: 24763434
[TBL] [Abstract][Full Text] [Related]
3. Mouse model of proximal colon-specific tumorigenesis driven by microsatellite instability-induced Cre-mediated inactivation of Apc and activation of Kras.
Kawaguchi Y; Hinoi T; Saito Y; Adachi T; Miguchi M; Niitsu H; Sasada T; Shimomura M; Egi H; Oka S; Tanaka S; Chayama K; Sentani K; Oue N; Yasui W; Ohdan H
J Gastroenterol; 2016 May; 51(5):447-57. PubMed ID: 26361962
[TBL] [Abstract][Full Text] [Related]
4. Loss of single immunoglobulin interlukin-1 receptor-related molecule leads to enhanced colonic polyposis in Apc(min) mice.
Xiao H; Yin W; Khan MA; Gulen MF; Zhou H; Sham HP; Jacobson K; Vallance BA; Li X
Gastroenterology; 2010 Aug; 139(2):574-85. PubMed ID: 20416302
[TBL] [Abstract][Full Text] [Related]
5. Combined Mutation of
Sakai E; Nakayama M; Oshima H; Kouyama Y; Niida A; Fujii S; Ochiai A; Nakayama KI; Mimori K; Suzuki Y; Hong CP; Ock CY; Kim SJ; Oshima M
Cancer Res; 2018 Mar; 78(5):1334-1346. PubMed ID: 29282223
[TBL] [Abstract][Full Text] [Related]
6. TSC1 loss synergizes with KRAS activation in lung cancer development in the mouse and confers rapamycin sensitivity.
Liang MC; Ma J; Chen L; Kozlowski P; Qin W; Li D; Goto J; Shimamura T; Hayes DN; Meyerson M; Kwiatkowski DJ; Wong KK
Oncogene; 2010 Mar; 29(11):1588-97. PubMed ID: 19966866
[TBL] [Abstract][Full Text] [Related]
7. Colon-specific tumorigenesis in mice driven by Cre-mediated inactivation of Apc and activation of mutant Kras.
Byun AJ; Hung KE; Fleet JC; Bronson RT; Mason JB; Garcia PE; Crott JW
Cancer Lett; 2014 Jun; 347(2):191-5. PubMed ID: 24632531
[TBL] [Abstract][Full Text] [Related]
8. Development of a colon cancer GEMM-derived orthotopic transplant model for drug discovery and validation.
Martin ES; Belmont PJ; Sinnamon MJ; Richard LG; Yuan J; Coffee EM; Roper J; Lee L; Heidari P; Lunt SY; Goel G; Ji X; Xie Z; Xie T; Lamb J; Weinrich SL; VanArsdale T; Bronson RT; Xavier RJ; Vander Heiden MG; Kan JL; Mahmood U; Hung KE
Clin Cancer Res; 2013 Jun; 19(11):2929-40. PubMed ID: 23403635
[TBL] [Abstract][Full Text] [Related]
9. Deregulation of the PI3K and KRAS signaling pathways in human cancer cells determines their response to everolimus.
Di Nicolantonio F; Arena S; Tabernero J; Grosso S; Molinari F; Macarulla T; Russo M; Cancelliere C; Zecchin D; Mazzucchelli L; Sasazuki T; Shirasawa S; Geuna M; Frattini M; Baselga J; Gallicchio M; Biffo S; Bardelli A
J Clin Invest; 2010 Aug; 120(8):2858-66. PubMed ID: 20664172
[TBL] [Abstract][Full Text] [Related]
10. TAK1 inhibition promotes apoptosis in KRAS-dependent colon cancers.
Singh A; Sweeney MF; Yu M; Burger A; Greninger P; Benes C; Haber DA; Settleman J
Cell; 2012 Feb; 148(4):639-50. PubMed ID: 22341439
[TBL] [Abstract][Full Text] [Related]
11. Mouse model of colonic adenoma-carcinoma progression based on somatic Apc inactivation.
Hinoi T; Akyol A; Theisen BK; Ferguson DO; Greenson JK; Williams BO; Cho KR; Fearon ER
Cancer Res; 2007 Oct; 67(20):9721-30. PubMed ID: 17942902
[TBL] [Abstract][Full Text] [Related]
12. PTEN loss and KRAS activation leads to the formation of serrated adenomas and metastatic carcinoma in the mouse intestine.
Davies EJ; Marsh Durban V; Meniel V; Williams GT; Clarke AR
J Pathol; 2014 May; 233(1):27-38. PubMed ID: 24293351
[TBL] [Abstract][Full Text] [Related]
13. Colon Tumors with the Simultaneous Induction of Driver Mutations in APC, KRAS, and PIK3CA Still Progress through the Adenoma-to-carcinoma Sequence.
Hadac JN; Leystra AA; Paul Olson TJ; Maher ME; Payne SN; Yueh AE; Schwartz AR; Albrecht DM; Clipson L; Pasch CA; Matkowskyj KA; Halberg RB; Deming DA
Cancer Prev Res (Phila); 2015 Oct; 8(10):952-61. PubMed ID: 26276752
[TBL] [Abstract][Full Text] [Related]
14. Colonic polyposis caused by mTOR-mediated chromosomal instability in Apc+/Delta716 Cdx2+/- compound mutant mice.
Aoki K; Tamai Y; Horiike S; Oshima M; Taketo MM
Nat Genet; 2003 Dec; 35(4):323-30. PubMed ID: 14625550
[TBL] [Abstract][Full Text] [Related]
15. Resveratrol prevents tumorigenesis in mouse model of Kras activated sporadic colorectal cancer by suppressing oncogenic Kras expression.
Saud SM; Li W; Morris NL; Matter MS; Colburn NH; Kim YS; Young MR
Carcinogenesis; 2014 Dec; 35(12):2778-86. PubMed ID: 25280562
[TBL] [Abstract][Full Text] [Related]
16. A target-selected Apc-mutant rat kindred enhances the modeling of familial human colon cancer.
Amos-Landgraf JM; Kwong LN; Kendziorski CM; Reichelderfer M; Torrealba J; Weichert J; Haag JD; Chen KS; Waller JL; Gould MN; Dove WF
Proc Natl Acad Sci U S A; 2007 Mar; 104(10):4036-41. PubMed ID: 17360473
[TBL] [Abstract][Full Text] [Related]
17. The role of Pygo2 for Wnt/ß-catenin signaling activity during intestinal tumor initiation and progression.
Talla SB; Brembeck FH
Oncotarget; 2016 Dec; 7(49):80612-80632. PubMed ID: 27811361
[TBL] [Abstract][Full Text] [Related]
18. Generation of an inducible colon-specific Cre enzyme mouse line for colon cancer research.
Tetteh PW; Kretzschmar K; Begthel H; van den Born M; Korving J; Morsink F; Farin H; van Es JH; Offerhaus GJ; Clevers H
Proc Natl Acad Sci U S A; 2016 Oct; 113(42):11859-11864. PubMed ID: 27708166
[TBL] [Abstract][Full Text] [Related]
19. Chemopreventive efficacy of rapamycin on Peutz-Jeghers syndrome in a mouse model.
Wei C; Amos CI; Zhang N; Zhu J; Wang X; Frazier ML
Cancer Lett; 2009 May; 277(2):149-54. PubMed ID: 19147279
[TBL] [Abstract][Full Text] [Related]
20. Reduction in alkaline sphingomyelinase in colorectal tumorigenesis is not related to the APC gene mutation.
Hertervig E; Nilsson A; Nilbert M; Duan RD
Int J Colorectal Dis; 2003 Jul; 18(4):309-13. PubMed ID: 12774245
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
